Search for: "Teva Pharmaceutical"
Results 601 - 620
of 1,429
Sort by Relevance
|
Sort by Date
20 Jan 2015, 7:14 am
The opinion in Teva Pharmaceuticals USA, Inc. v. [read post]
20 Jan 2015, 7:07 am
Breyer delivered the opinion of the Court in Teva Pharmaceuticals USA, Inc. v. [read post]
18 Jan 2015, 3:52 am
This Katpost discusses Teva v Leo and whether ‘reasonable expectation of success’ should have been used as part of inventive step analysis. [read post]
15 Jan 2015, 9:57 am
At its Conference on January 16, 2015, the Court will consider petitions seeking review of issues such as liability for a priest’s failure to report inappropriate sexual conduct, scope of the exhaustion requirement in a takings claim, the Heck v. [read post]
5 Jan 2015, 1:26 pm
The prior published opinion in this case, Teva Pharmaceuticals USA, Inc. v. [read post]
3 Jan 2015, 9:41 am
On January 20, 2015, the Supreme Court issued its decision in Teva Pharmaceuticals USA, Inc. v. [read post]
31 Dec 2014, 5:00 am
Xanodyne Pharmaceuticals, Inc., 771 F.3d 1218 (9th Cir. 2014) (en banc). [read post]
18 Dec 2014, 11:56 am
Supreme Court invitation brief in generic prescription drug failure to update warning label case initiated in California state court: You can access the CVSG brief filed today in Teva Pharmaceuticals USA, Inc. v. [read post]
7 Dec 2014, 9:03 pm
Teva Pharmaceuticals USA Inc. 1:14-cv-01451; filed December 2, 2014 in the District Court of Delaware • Plaintiffs: Reckitt Benckiser Pharmaceuticals Inc.; RB Pharmaceuticals Ltd.; MonoSol Rx LLC • Defendant: Teva Pharmaceuticals USA Inc. [read post]
5 Dec 2014, 9:00 am
Teva Pharmaceuticals USA, Inc., 731 F.3d 918 (9th Cir. 2013). [read post]
2 Dec 2014, 12:27 pm
Supreme Court heard argument six weeks ago in Teva Pharmaceuticals USA v. [read post]
21 Nov 2014, 4:00 am
Over the past few years the pharmaceutical marketplace has seen an increase in patent “re-litigation” (where a patentee is involved in a second case against another generic). [read post]
12 Nov 2014, 10:15 am
Janssen and Teva file to protect Chicago disclosing trade secrets: Back in the summer, the city of Chicago commenced proceedings against several pharmaceutical companies, including Janssen, Purdue Pharma LP, Teva and Actavis alleging that they dishonestly marketed opioid painkillers including Oxycontin and Percocet for the treatment of common and non-cancer related chronic pain resulting in a reported public health crisis of addiction and abuse. [read post]
7 Nov 2014, 5:52 am
Teva Pharmaceuticals USA, Inc., 819 F. [read post]
30 Oct 2014, 12:02 pm
“Some of the biggest generic drug companies — Mylan, Actavis and Teva Pharmaceutical Industries — have been aggressively snapping up other manufacturers in recent years,” Lazarus wrote, “reducing the number of players in the market. [read post]
30 Oct 2014, 11:34 am
Note Reuters post Teva optimistic U.S. top court to rule in favor of MS drug patent with textTeva Pharmaceutical Industries is optimistic the U.S. [read post]
27 Oct 2014, 5:27 am
* Obviousness, common general knowledge and expectations of success: Leo gets a mauling Jeremy hosts this post by Suleman Ali (Holly IP) on Teva UK Limited & Teva Pharmaceuticals Limited v Leo Pharma A/S & Leo Laboratories Limited [2014] EWHC 3096 (Pat), a decision by Mr Justice Birss in the Patents Court, England and Wales which addresses two patent law cornerstones: obviousness and common general knowledge. [read post]
21 Oct 2014, 9:03 am
Teva Pharmaceuticals USA, Inc., the Federal Circuit panel affirmed a lower court finding that BMS’s patent covering the Hep-B drug entecavir is invalid as obvious. [read post]
21 Oct 2014, 12:00 am
The author is occasional and much-appreciated guest contributor Suleman Ali (Holly IP), who writes as follows:Teva UK Limited & Teva Pharmaceuticals Limited v Leo Pharma A/S & Leo Laboratories Limited[2014] EWHC 3096 (Pat) is a decision by Mr Justice Birss in the Patents Court, England and Wales. [read post]
20 Oct 2014, 10:00 pm
Teva Pharmaceuticals, USA, Inc. [read post]
